Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-Viral, Plasmid-Free CAR T Manufacturing Platform

Stock Information for Applied DNA Sciences Inc.

Loading

Please wait while we load your information from QuoteMedia.